Submission Details
| 510(k) Number | K201219 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 06, 2020 |
| Decision Date | January 19, 2021 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K201219 is an FDA 510(k) clearance for the Biocore9 Femoral Head Resurfacing Component, a Prosthesis, Hip, Femoral, Resurfacing (Class II — Special Controls, product code KXA), submitted by Biocore9, LLC (Whippany, US). The FDA issued a Cleared decision on January 19, 2021, 258 days after receiving the submission on May 6, 2020. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3400.
| 510(k) Number | K201219 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 06, 2020 |
| Decision Date | January 19, 2021 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | KXA — Prosthesis, Hip, Femoral, Resurfacing |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3400 |